Related by context. All words. (Click for frequent words.) 69 refractory diffuse 69 relapsed refractory aggressive 69 previously untreated follicular 67 radioimmunotherapeutic agent 64 CVP cyclophosphamide vincristine 64 follicular B 63 rituximab refractory follicular 62 relapsed indolent 62 relapsed follicular 61 refractory indolent non 61 rituximab refractory 61 refractory indolent NHL 60 small lymphocytic lymphoma 60 CHOP cyclophosphamide doxorubicin vincristine 60 relapsed mantle 60 prednisolone chemotherapy 60 systemic anaplastic large 60 refractory acute promyelocytic 60 indolent lymphoma 59 Relapsed 59 cyclophosphamide doxorubicin vincristine 59 refractory colorectal cancer 59 CVP chemotherapy 59 multiple myeloma MM 58 relapsed refractory 58 refractory chronic lymphocytic 58 non Hodgkin lymphomas 58 follicular Non Hodgkin 58 Diffuse Large B 58 refractory acute myeloid 58 CHOP chemotherapy 57 relapsed indolent NHL 57 follicular CD# positive 57 antigen CD# 57 Non Hodgkin 57 HuMax R 57 taxane chemotherapy administered 57 Non Hodgkin Lymphoma 57 refractory myeloma 56 mitoxantrone plus 56 Ph + acute lymphoblastic 56 Follicular lymphoma 56 indolent NHL 56 Non Hodgkin lymphoma 55 systemic ALCL 55 Personalized Immunotherapy 55 demonstrated antitumor activity 55 advanced carcinoid 55 refractory cutaneous T 55 leukemia CLL 55 CLL SLL 55 DLBCL 55 plus prednisone prednisolone 55 indolent follicular non 54 lymphoma Hodgkin lymphoma 54 Pathway Inhibitor 54 anthracycline derivative 54 Peginterferon alfa 2b 54 undergoing hematopoietic stem 54 EGFR expressing mCRC 54 EGFR mutation positive 54 cyclophosphamide doxorubicin 54 irinotecan containing 54 lymphoma CTCL 54 RIS NASN ASN 54 refractory CTCL 54 anthracycline taxane 54 Hodgkin lymphoma HL 54 Non Hodgkin Lymphomas 54 follicular NHL 54 ® lenalidomide 54 relapsed acute lymphoblastic 53 Relapsed Refractory 53 nonmetastatic 53 small molecule Hedgehog 53 Rituxan MabThera 53 macroglobulinemia 53 refractory NSCLC 53 dasatinib Sprycel 53 bendamustine 53 Panzem R NCD 53 recurrent metastatic 53 PNP inhibitor 53 p#HER# positive 53 remission induction 53 anthracyclines taxanes 53 Relapsed Refractory Aggressive 53 Non Hodgkins Lymphoma 53 imatinib therapy 53 relapsed 52 refractory Hodgkin 52 Bcr Abl T#I mutation 52 metastatic bladder 52 metastatic renal 52 enforcer Probert 52 Stage IIIB IV 52 Scoring summaries 52 5 FU leucovorin 52 refractory multiple myeloma 52 PI3K/Akt pathway inhibitor 52 Kenndal McArdle netted 52 MAGE A3 ASCI 52 lymphoid malignancies 52 estramustine 52 forodesine 52 clinicopathological features 52 hA# 52 metastatic pancreatic 52 refractory CLL 52 Kit CD# positive 52 Temsirolimus 52 patients coinfected 52 Officially Licensed Product 52 non Hodgkins Lymphoma 52 PJ Axelsson Milan Lucic 52 recurrent malignant glioma 52 stage IIIb IV 52 castrate resistant 52 CML CP 52 dasatinib Sprycel ® 52 non splenectomized 52 docetaxel Injection Concentrate 52 BRCA deficient 52 NMIBC 52 plus prednisone 52 gemcitabine Gemzar ® 52 haematologic 52 EGFR tyrosine kinase inhibitor 52 SPRYCEL ® 52 Arzerra ofatumumab 52 milatuzumab 52 Chronic Lymphocytic Leukemia CLL 52 Non Hodgkins lymphoma 52 Amrubicin 52 Chronic lymphocytic leukemia CLL 51 CYT# potent vascular disrupting 51 cell chronic lymphocytic 51 lung pancreatic 51 FOLFOX chemotherapy 51 relapsed Acute Myeloid 51 EGFR expressing 51 tumors GIST 51 taxane therapy 51 NSCL cancer 51 vinflunine 51 novel histone deacetylase 51 Rituxan rituximab 51 refractory 51 Tarceva TM 51 metastatic gastric 51 TNF blocker therapy 51 follicular non 51 heavily pretreated 51 selective modulator 51 Follicular 51 imatinib resistant 51 Apoptone 51 leukemia APL 51 progression TTP 51 metastatic malignant 51 alkylating agent 51 relapsing remitting MS RRMS 51 cell lymphoma CTCL 51 prognostic biomarker 51 superficial bladder cancer 51 MabThera Rituxan 51 papillary renal cell carcinoma 51 refractory DLBCL 51 cutaneous T 51 follicular lymphoma 51 PR Newswire Rodale 51 relapsed leukemia 51 plus dacarbazine 51 imatinib Gleevec ® 51 inhaled liposomal ciprofloxacin 51 thetreatment 51 gemcitabine carboplatin 51 HRPC 51 relapsed ovarian cancer 51 non resectable 51 non constipating irritable 51 taxane refractory 51 completely resected 51 acute myeloid 50 Stage IIB 50 fallopian tube cancers 50 Abiraterone acetate 50 dose escalation clinical 50 generation purine nucleoside 50 Ofatumumab 50 refractory acute lymphoblastic 50 fludarabine cyclophosphamide 50 refractory peripheral T 50 ibritumomab tiuxetan 50 Vincristine 50 Alexei Ponikarovsky Chad Kilger 50 SYRACUSE CRUNCH Announced 50 adriamycin 50 polycythemia vera essential thrombocythemia 50 non Hodgkin Lymphoma 50 Refractory Hodgkin Lymphoma 50 T1c 50 advanced metastatic renal 50 recurrent NSCLC 50 deflected Joe Corvo 50 pain palliation 50 Cloretazine ® 50 relapsed MM 50 histone deacetylase HDAC inhibitor 50 Amgen Neulasta R 50 non metastatic resectable 50 T Cell Lymphoma 50 Adjuvant chemotherapy 50 patients receiving myelosuppressive 50 recurrent glioblastoma multiforme 50 paclitaxel Taxol R 50 Xeloda ® 50 refractory metastatic 50 Sanofi Aventis Taxotere 50 trastuzumab Herceptin R 50 non myeloid malignancies 50 Tomas Holmstrom Pavel Datsyuk 50 LHRH receptor positive 50 mouse xenograft models 50 targeted radiotherapeutic 50 Annamycin 50 phase Ib 50 refractory gastrointestinal stromal 50 Pahlsson finalist 50 pancreatic colon 50 metastatic carcinoma 50 pediatric acute lymphoblastic 50 Akt inhibitor 50 Genasense ® 50 Evoltra ® 50 Named CCM Vector 50 AVASTIN 50 BCG refractory 50 Nexavar tablets 50 Lemieux bashes 50 Cutaneous T 50 idiopathic thrombocytopenic purpura 50 receiving highly emetogenic 50 Zenvia ™ 50 KRAS mutant 50 adjuvant cisplatin 50 doublet chemotherapy 50 BRAF V# mutation 50 follicular lymphoma FL 50 lenalidomide Revlimid R 50 ZEVALIN 50 ribavirin therapy 50 Chronic Myelogenous Leukemia CML 50 Thalomid ® 50 novel VDA molecule 50 de novo kidney transplant 49 Saku Koivu Andrei Kostitsyn 49 chronic lymphocytic leukemia CLL 49 HER2 positive metastatic breast 49 Fludarabine 49 Mantle Cell Lymphoma 49 #mg/m# [001] 49 chemotherapy docetaxel 49 TO AVOID PREGNANCY WHILE 49 xenograft models 49 Newlyweds Carrie Underwood 49 visceral metastases 49 pegylated interferon peg IFN 49 TEAM LEADERS Mighty Ducks 49 taxane resistant 49 pediatric pontine glioma 49 Anaplastic large 49 Gleevec imatinib mesylate 49 MDS AML 49 hematopoietic cancers 49 Acute Myeloid Leukemia AML 49 bacillus Calmette Guerin 49 refractory AML 49 cyclophosphamide methotrexate 49 Epratuzumab 49 essential thrombocythemia ET 49 Taxotere chemotherapy 49 deletion 5q 49 IMiDs ® 49 Milan Lucic Dennis Seidenberg 49 docetaxel Taxotere ® 49 alvespimycin 49 REVLIMID R 49 efaproxiral 49 chemoresistant 49 advanced medullary thyroid 49 leukemia AML 49 oral clodronate 49 relapsed acute myelogenous 49 unresectable locally advanced 49 refractory systemic anaplastic 49 gastrointestinal stromal tumor GIST 49 resistant hormone refractory 49 metastatic SCCHN 49 FUSILEV enhances 49 Ribavirin causes 49 recombinant interferon 49 HER2 negative 49 player Jere Karalahti 49 Martin Skoula Marian Gaborik 49 cisplatin gemcitabine 49 exocrine pancreatic insufficiency EPI 49 hoFH 49 sorafenib tablets 49 mycosis fungoides 49 Nikolai Kulemin backhander 49 cutaneous T cell 49 PEGylated anti 49 Follicular Lymphoma 49 heavily pretreated patients 49 receptor tyrosine kinase inhibitor 49 Cell Non Hodgkin 49 Solid Tumors criteria 49 Allovectin 7 ® 49 androgen independent 49 ovarian carcinoma 49 relapsed refractory multiple myeloma 49 irinotecan doxorubicin oxaliplatin paclitaxel 49 anthracycline containing 49 cytarabine daunorubicin 49 MyVax R 49 oropharyngeal candidiasis OPC 49 cyclophosphamide chemotherapy 49 lintuzumab 49 Telintra 49 5 fluorouracil leucovorin 49 SEER database 49 fallopian tube carcinoma 49 Vidaza azacitidine 49 neuropathy sparing 49 Niklas Hagman Philippe Boucher 49 Phase #b/#a clinical 49 stage IIIB 49 acute GvHD 49 Soft Tissue Sarcoma 49 refractory lymphoma 49 relapsed Hodgkin lymphoma 49 hormone refractory 49 Kyle Wellwood Sami Salo 49 2 methoxyestradiol 49 gefitinib Iressa 49 Bezielle 49 Taxotere docetaxel 48 antibody MAb 48 chemo immunotherapy 48 Backhand Assists 48 mycophenolate mofetil MMF 48 ® bortezomib 48 rhIGF-I/rhIGFBP-3 48 lumiliximab 48 Recalled RW 48 unresectable Stage III 48 induced anemia 48 VELCADE melphalan 48 Kovalchuk Tobias Enstrom 48 surgically resectable 48 biologic therapy 48 cell lymphoma DLBCL 48 unresectable recurrent 48 Gleevec resistant 48 Voreloxin 48 prostate carcinoma 48 radiation sensitizer 48 histologic subtype 48 galiximab 48 immune thrombocytopenic purpura 48 histologies 48 BN# [004] 48 Phase #/#a trial 48 severe hypersensitivity reactions 48 personalized immunotherapy 48 Hodgkin lymphoma NHL 48 By Matt Canamucio 48 potentially hepatotoxic 48 HGS ETR1 48 Pemetrexed 48 Shootout Goal Lifts 48 administered concomitantly 48 allogeneic bone marrow 48 Luteinizing Hormone Releasing Hormone 48 Playoff Summaries 48 cytokine refractory 48 mitoxantrone chemotherapy 48 thalidomide Thalomid 48 pegylated liposomal doxorubicin 48 resistant ovarian cancer 48 Sergei Fedorov Steve Yzerman 48 monoclonal antibody conjugated 48 Jack Skille Rene Bourque 48 doxorubicin Adriamycin 48 detectable HCV RNA 48 hypereosinophilic syndrome 48 Chronic myeloid leukemia 48 ixabepilone 48 dextromethorphan quinidine 48 unresectable 48 operable breast cancer 48 adjuvant systemic 48 mRCC 48 AKT inhibitor 48 chronic HCV 48 Omacetaxine 48 HSP# inhibitor 48 Specifid 48 sorafenib Nexavar 48 ofatumumab 48 Darinaparsin 48 FavId 48 Temodar ® 48 epithelial tumors 48 Bevacizumab Avastin 48 carcinoma mCRC 48 Ryan Kesler Alex Burrows 48 imatinib Gleevec 48 cytotoxic therapy 48 KIACTA ™ 48 relapsed CLL 48 evaluating tivozanib 48 defensemen Steve Montador 48 cisplatin carboplatin 48 Acute myelogenous leukemia 48 vinorelbine 48 PEGylated interferon beta 1a 48 decompensated liver disease 48 pomalidomide 48 oral prodrug 48 immune dysregulation 48 Novartis Afinitor 48 non Hodgkin lymphoma 48 Targeted Therapy 48 antiangiogenic therapy 48 GLENDALE Ariz. Phoenix Coyotes 48 myelodysplastic myeloproliferative diseases 48 malignant ascites 48 TEAM LEADERS Canucks 48 Revlimid lenalidomide 48 immunomodulatory therapy 48 biliary tract cancer 48 neutropenia dehydration dyspnea 48 NSCLC 48 TEAM LEADERS Maple Leafs 48 lymphocytic leukemia 48 Sudhir Agrawal D.Phil 48 metastatic carcinoid 48 acute lymphoblastic 48 metastatic renal cell 48 stage IIIb 48 cell malignancies 48 ZOLINZA 48 acute mania 48 bortezomib Velcade 48 B CLL 48 hormone refractory metastatic prostate 48 Seliciclib 48 Assigned LW 48 dacarbazine DTIC 48 locoregional recurrence 48 allogeneic HSCT 48 Huselius Umberger 47 alfa 2a 47 Folfox 47 treatment naive genotype 47 Third Period 8 47 CPOP R 47 metastatic renal cell carcinoma 47 non metastatic osteosarcoma 47 ATLANTA THRASHERS Recalled 47 CIMZIA R 47 severe oral mucositis 47 Campath alemtuzumab 47 Anthracycline 47 pediatric malignancies 47 registrational trial 47 EOquin TM 47 Sabres Sums 47 Brendan Shanahan Jaromir Jagr 47 haematological cancers 47 Glen Metropolit Guillaume Latendresse 47 Alequel 47 low dose cytarabine 47 IL# PE#QQR 47 LymphoStat B belimumab 47 prednisone CHOP 47 temsirolimus 47 Benlysta belimumab 47 EOquin 47 diagnosed Ph + 47 melphalan prednisone 47 Certolizumab pegol 47 Tomas Holmstrom Brian Rafalski 47 acute leukemias 47 amrubicin 47 FOLFOX regimen 47 metastatic colorectal 47 cell lymphoma MCL 47 motesanib 47 Hormone Refractory Prostate Cancer 47 histologically confirmed 47 rALLy 47 AML acute myeloid 47 Cimzia TM 47 histological subtypes 47 Clolar ® 47 Pho roughing #:# 47 paclitaxel carboplatin 47 nilotinib Tasigna ® 47 Treanda 47 YONDELIS 47 Imatinib mesylate 47 advanced hepatocellular carcinoma 47 advanced nonsquamous NSCLC 47 cetuximab Erbitux ® 47 Ceflatonin 47 non resectable metastatic 47 Nigel Dawes Petr Prucha 47 secondary hyperparathyroidism 47 xanthine oxidase inhibitor 47 PEGylated Fab fragment 47 oral anti arrhythmic 47 GMX# 47 Gleevec Glivec 47 ACAPODENE TM 47 Pavel Datsyuk Kris Draper 47 neratinib 47 paclitaxel Taxol ® 47 Chuck Kobasew Dennis Wideman 47 thymoma 47 Coyotes Sums 47 HNSCC 47 Dr. Karl Mettinger 47 relapsed multiple myeloma 47 Dacogen injection 47 NHL ROUNDUP 47 metastatic castration resistant 47 Letairis ambrisentan 47 Richard Zednik Radek Dvorak 47 Aflibercept 47 myeloablative 47 Decitabine 47 etoposide 47 node metastases 47 refractory Hodgkin lymphoma 47 Rituximab 47 RITUXAN ® 47 IV metastatic melanoma 47 veltuzumab 47 Inc. Televisa Shareholder.com 47 ER CHOP 47 Immunosuppressive 47 myeloid metaplasia 47 infliximab monotherapy 47 carboplatin paclitaxel 47 pretransplant 47 colon carcinoma 47 advanced HER2 positive 47 keloid scarring 47 registrational 47 Arranon 47 Vidaza ® 47 Bosutinib 47 cetuximab Erbitux 47 TransMID TM 47 pediatric Crohn disease 47 Cytarabine 47 beta 1a 47 weekly subcutaneous injections 47 Rookie Mats Zuccarello 47 Defensemen Kim Johnsson 47 subcutaneous methylnaltrexone 47 NYR slashing #:# 47 plus DOXIL 47 JP Dumont Shea Weber 47 SOM# 47 Aplidin 47 #mg/m# [002] 47 ANAHEIM MIGHTY 47 neutropenic 47 fludarabine phosphate 47 Surgical resection 47 Curtis Glencross Dustin Penner 47 dirucotide MBP# 47 radiotherapy RT 47 induce remission 47 Thomas Vanek Jason Pominville 47 refractory metastatic colorectal cancer 47 ROSTER UPDATES Edmonton 47 cytoreduction 47 alanine transaminase ALT 47 papillary thyroid carcinoma 47 TREANDA 47 NYR roughing #:# 47 evaluating REVLIMID 47 Nashville Anders Lindback 47 5-fluorouracil/leucovorin 47 hereditary pancreatitis 47 localized renal 47 taxotere 47 Cloretazine 47 Paraplatin ® 47 DOXIL ® 47 resectable 47 advanced metastatic prostate 47 cancer neuroendocrine tumor 47 tositumomab 47 refractory APL 47 chronic myeloid 47 Archexin 47 peginterferon alpha 2a 47 mapatumumab 47 recurrent genital herpes 47 conventional DMARDs 47 immune modulating 47 chronic HBV infection 47 antithymocyte globulin 47 Chronic lymphocytic leukemia 47 FOLFIRI alone 47 lymphoproliferative disorders 47 Onco TCS 47 proteasome inhibitor 47 opioid induced constipation OIC 47 neurologic progression 47 pancreatic neuroendocrine tumors 47 refractory ovarian cancer 47 cell lymphoma ALCL 47 Francis Bouillon Andrei Markov 47 achieve sustained virologic 47 taxane chemotherapy 47 Maxim Lapierre Guillaume Latendresse 46 CLARITY study 46 Pegloticase 46 Novantrone 46 baseline LDH 46 huN# DM1 46 erlotinib Tarceva ® 46 Patients Treated With 46 panitumumab Vectibix 46 Fludara ® 46 glufosfamide 46 haematologic malignancies 46 cetuximab Erbitux R 46 idiopathic thrombocytopenic purpura ITP 46 Helicobacter pylori eradication 46 virus HBV infection 46 temozolomide TMZ 46 leukemia ALL 46 prostatic adenocarcinoma 46 Scott Hartnell Danny Briere 46 MGd 46 Gel repository corticotropin injection 46 intravenous belinostat 46 pamidronate 46 KRAS wild 46 untreated metastatic pancreatic 46 TEMODAL 46 Raptiva ® 46 FOLFOX6 46 Pharmacokinetics PK 46 gemcitabine Gemzar 46 Tanguay Koivu 46 Tiuxetan 46 Interferon beta 46 Octreolin 46 lenalidomide dexamethasone 46 cell acute lymphoblastic 46 APOPTONE 46 PCNSL 46 chimeric monoclonal antibody 46 MALT lymphoma 46 Second Period 2 NY 46 refractory prostate cancer 46 relapsed SCLC 46 evaluating Xcytrin 46 rookie Mark Letestu 46 Genentech Rituxan 46 corticotropin injection 46 hepatocellular carcinoma HCC 46 gastrointestinal stromal tumors 46 TELINTRA 46 recurrent glioblastoma 46 Slap Shot Assists 46 liposomal formulation 46 Gemzar gemcitabine 46 BCG refractory carcinoma 46 Kirk Maltby Tomas Holmstrom 46 Ondrej Pavelec Save 46 calcineurin inhibitor 46 Danny Briere Simon Gagne 46 nucleotide analog 46 cell lymphomas 46 Pivotal Study 46 refractory PTCL 46 Dany Heatley Shane Doan 46 cilengitide 46 pT3 46 metastatic hormone refractory 46 ZACTIMA 46 RoACTEMRA 46 HP Acthar Gel repository 46 MyVax ® 46 sodium stibogluconate 46 axitinib 46 Pittsburgh Engelland Rupp 46 BARACLUDE ® 46 relapsed follicular lymphoma 46 BUFFALO NY Ales Kotalik 46 rufinamide 46 #-#-# OVER UNDER [001] 46 Selke finalists 46 gemtuzumab ozogamicin 46 refractory Ph + 46 achieved ACR# 46 cytogenetic responses 46 recurrent GBM 46 ELACYT 46 bevacizumab Avastin ® 46 metastatic GIST 46 fluorouracil leucovorin 46 YONDELIS R 46 EDMONTON Alberta Fernando Pisani 46 HuMax CD4 46 COLUMBUS BLUE 46 histological subtype 46 BR.# 46 IIa clinical trial 46 hypomethylating agents 46 Doxil ® 46 Edmonton goalie Nikolai 46 standard chemotherapy regimen 46 oral methylnaltrexone 46 relapsing remitting multiple sclerosis 46 CR CRu 46 liposomal doxorubicin 46 8mg/kg 46 metaglidasen 46 class mGluR5 inhibitor 46 IIb IV 46 chronic lymphocytic 46 omacetaxine mepesuccinate 46 Toxicities 46 debulking surgery 46 surgical prophylaxis 46 IIa trial 46 trabectedin 46 alefacept 46 Ibritumomab Tiuxetan 46 mutated K ras 46 atypical hemolytic uremic syndrome 46 AQ4N 46 backup goalie Antero 46 differentiated thyroid 46 octreotide implant 46 esophageal candidiasis 46 neoadjuvant 46 Reassigned G 46 FOLFIRI 46 cancer mCRC 46 refractory ALCL 46 leukaemias 46 IMPDH inhibitor 46 Phase III randomized controlled 46 Chris Chelios Tomas Holmstrom 46 Avalanche Quebec Nordiques 46 alkylating agents 46 CCyR 46 virus HCV protease inhibitor 46 phase Ph + 46 metastatic medullary thyroid 46 Targretin capsules 46 baminercept 46 non hodgkin lymphoma 46 childhood acute lymphoblastic 46 Ph + 46 castration resistant prostate cancer 46 VNP#M 46 intralesional 46 Chronic Myeloid Leukemia CML 46 myeloproliferative diseases 46 acquired defenseman Janne 46 nonmyeloablative 46 Mathieu Darche Tomas Plekanec 46 Anaplastic 46 Ryan Potulny Ethan Moreau 46 bladder carcinoma 46 plus gemcitabine 46 placebo intravenously 46 liposomal amphotericin B 46 PROVIDENCE BRUINS Announced 46 temozolomide Temodar 46 anti tumoral 46 elacytarabine 46 cell carcinoma RCC 46 advanced epithelial ovarian 46 Cytoxan 46 Maple Leafs Sums 46 unresectable stage 46 hepatic metastases 46 oral ridaforolimus 46 pegylated alpha interferon 46 MabCampath 46 vinca alkaloid 46 RECIST Response Evaluation Criteria 46 tumor xenograft models 46 unique alkylating agent 46 acute promyelocytic leukemia APL 46 metastatic castrate resistant 46 null responder HCV 46 antiestrogen therapy 46 prostate cancer CRPC 46 IV melanoma 46 non squamous histology 46 defenseman Kevin Connauton 46 Cotara ® 46 relapsing multiple sclerosis 46 leukemia lymphoma multiple myeloma 46 commercialize deforolimus 46 Olli Jokinen Nathan Horton 46 leukemia CML 46 Bertuzzi reinstatement 46 PD LID 46 Ozarelix 46 defensemen Martin Skoula 46 etanercept Enbrel 46 Jiri Hudler Darren Helm 46 Johan Franzen Henrik Zetterberg 46 PEG IFN 46 rituximab 46 gemcitabine cisplatin 46 finasteride Proscar 46 Probable goaltenders Marc Andre 46 antimetabolite 46 dosing cohort 46 precursor lesions 45 mutated KRAS gene 45 Ducks Sums 45 skeletal metastases 45 dalteparin 45 splenectomized 45 Francois Beauchemin Travis Moen 45 refractory SCLC 45 Red Wings Sums 45 antiretroviral naïve 45 Datsyuk Kesler 45 Riluzole 45 Major Depressive Disorder MDD 45 doxorubicin cyclophosphamide 45 OHR/AVR# 45 Thrashers Sums 45 situ CIS 45 metastatic uveal melanoma 45 Medullary thyroid cancer 45 autoantibody positive 45 humanised monoclonal antibody 45 steroid refractory ulcerative 45 pharmacodynamic PD 45 BOSTON PIZZA WHL 45 SUNRISE Fla. Rich Peverley 45 Olli Jokinen centering 45 erythema nodosum 45 acute myelogenous leukemia AML 45 Canucks Sums 45 tumor lysis syndrome 45 arthritis PsA 45 visilizumab 45 trastuzumab Herceptin ® 45 myelogenous leukemia 45 mTOR inhibitor 45 Predators Sums 45 R bendamustine hydrochloride 45 postoperative chemotherapy 45 breast carcinomas 45 blinatumomab 45 PDX pralatrexate 45 Andrew Brunette tallied 45 non splenectomised 45 docetaxel chemotherapy 45 Oilers Sums 45 toenail onychomycosis 45 fosbretabulin 45 Irinotecan 45 oral squamous cell 45 Herceptin trastuzumab 45 relapsed AML 45 dacarbazine chemotherapy 45 breast pancreatic 45 TNF Tumor Necrosis Factor 45 rituximab Rituxan 45 pancreatic prostate 45 Pharmion Vidaza 45 dexanabinol 45 hormone refractory prostate cancer 45 KRAS mutant tumors 45 Derick Brassard Maksim Mayorov 45 Temodar temozolomide 45 backup goalie Jhonas 45 Daniel Tjarnqvist Jarret Stoll 45 chronic ITP patients 45 anti leukemic 45 ribavirin RBV 45 corticosteroid dexamethasone 45 predictive biomarker 45 dexamethasone Decadron 45 blanks Pens 45 D Ossi Vaananen 45 lymphoid blast 45 oral Hycamtin 45 Second Period 3 NY 45 SinuNase TM 45 prednisone prednisolone plus 45 Flyers Sums 45 defensemen Rob Scuderi 45 Myelodysplastic Syndrome 45 remitting MS 45 DITPA 45 atypical Hemolytic Uremic Syndrome 45 radiolabeled antibody 45 gemcitabine chemotherapy 45 Omnitarg 45 Degarelix 45 CR nPR 45 Mike Komisarek Brooks Orpik 45 aromatase inhibitor AI 45 goserelin 45 evaluable 45 Paraplatin ® carboplatin 45 REVLIMID ® 45 LHRH agonists 45 secondary hyperparathyroidism SHPT 45 potent antiproliferative 45 Vinorelbine 45 intravesical therapy 45 underwent surgical resection 45 Nas tripping #:# [002] 45 Onrigin 45 Avalanche Sums 45 lymphomas 45 Acute myeloid leukemia 45 cyclophosphamide FC 45 anti angiogenic agents 45 Rod Brind'Amour Cory Stillman 45 LHRH analogues 45 interleukin IL -# 45 NHLs 45 nucleoside analog 45 aMCI precursor 45 antiresorptive 45 Papillary 45 Mike Knuble Scott Hartnell 45 pulmonary exacerbation 45 Rookie defenseman Andrej 45 phase IIb trial 45 concurrent chemoradiation 45 decompensated cirrhosis 45 surgical debulking 45 ALB # 45 Previously Treated 45 luteinizing hormone releasing 45 oropharyngeal candidiasis 45 Pixantrone 45 Gemzar ® 45 paclitaxel Taxol 45 BEXXAR 45 maximally tolerated lipid lowering 45 5q deletion 45 subependymal giant cell 45 5-FU/LV 45 TTF Therapy 45 primary humoral immunodeficiency 45 castrate resistant prostate cancer 45 precursor acute lymphoblastic 45 hyperphenylalaninemia HPA due 45 cervical lymph nodes 45 motexafin gadolinium 45 sarcomatoid 45 vismodegib 45 Taxotere ® 45 cariprazine 45 tiuxetan 45 FOLFOX6 chemotherapy regimen 45 small molecule tyrosine 45 baseless Pat Brisson 45 farletuzumab 45 p# MAP kinase inhibitor 45 topically administered 45 romidepsin 45 Platinol ® 45 ara C 45 Oxaliplatin 45 HBeAg positive patients 45 epirubicin 45 urinary N telopeptide 45 PNH patients 45 metastatic sarcoma 45 defenseman Mikko Lehtonen 45 breast carcinoma